Munger Tolles Helps Abbott Defeat Bayer Patent Suit
Munger, Tolles & Olson attorneys successfully defeated a bid by Bayer AG to recover royalties from our client Abbott Laboratories for U.S. sales of the arthritis drug Humira.
A judgment entered on Jan. 11, 2011 in U.S. District Court of Massachusetts rejected the attempt by Bayer, which had sued Abbott in 2008 for patent infringement.
Following a Markman hearing, U.S. District Judge Dennis Saylor ruled in October that Bayer’s patent for antibodies could not be construed in a manner that would cover Humira, Abbott’s best-selling drug. The court accordingly entered a stipulated judgment of non-infringement. Bayer will now appeal the case to the United States Court of Appeals for the Federal Circuit.
Munger Tolles’ Jeffrey I. Weinberger led the team that also included Garth T. Vincent, Ted Dane, Jennifer L. Polse, Heather E. Takahashi and Adam R. Lawton.
Polse, Jennifer L.
Ph.D. 1996 Munger, Tolles & Olson LLP.
San Francisco Office
33 New Montgomery
Tower, 19th Floor
San Francisco, CA 94105-9781
Phone: (415) 512-4063
Fax: (415) 512-4077
MUNGER TOLLES & OLSON – Contact us
355 South Grand Ave.
Los Angeles, CA 90071
Phone: (213) 683-9100
560 Mission St.
San Francisco, CA 94105
Phone: (415) 512-4000
Progress Investment Management Company, LLC
33 New Montgomery Street 19th Floor , San Francisco , CA , 94105 , United States
Industry: Asset Management
SIC: Investment Offices (6720)
NAICS: Portfolio Management (523920)
Description: Founded during February of 1990, Progress focuses its efforts on the structuring and managing of multiple manager investment funds featuring emerging minority investment managers. The company’s manager universe includes a wide range of niche specialists and traditionally overlooked managers along with minority and woman-owned firms. The firm is responsible for managing over $3 billion in assets. Progress offers five commingled equity and fixed income investment funds serving 12 clients, one fund-of-funds private equity program serving six clients, and twelve multiple manager Separate Accounts. With the growth in managed assets, Progress has funded over 60 of the top minority-, women owned and non-minority emerging investment managers across the country since the firm’s inception. Progress is the largest and most experienced minority founded manager of emerging managers in the industry.